Theresa A Rowe1, Tiffany Brown2, Ji Young Lee2, Jeffrey A Linder2, Mark W Friedberg3,4,5, Jason N Doctor6, Daniella Meeker6, Jody D Ciolino2, Stephen D Persell2,7. 1. Division of General Internal Medicine and Geriatrics, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. theresa.rowe@northwestern.edu. 2. Division of General Internal Medicine and Geriatrics, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 3. RAND Corporation, Boston, MA, USA. 4. Blue Cross Blue Shield of Massachusetts, Boston, MA, USA. 5. Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA. 6. University of Southern California Keck School of Medicine, Los Angeles, CA, USA. 7. Center for Primary Care Innovation, Institute for Public Health and Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Abstract
IMPORTANCE: The extent of clinician-level variation in the overuse of testing or treatment in older adults is not well understood. OBJECTIVE: To examine clinician-level variation for three new measures of potentially inappropriate use of medical services in older adults. DESIGN: Retrospective analysis of overall means and clinician-level variation in performance on three new measures. SUBJECTS: Adults aged 65 years and older who had office visits with outpatient primary or immediate care clinicians within a single academic medical center health system between July 1, 2016, and June 30, 2017. MEASURES: Two electronic clinical quality measures representing potentially inappropriate use of medical services in older adults: prostate-specific antigen testing against guidelines (PSA) in men aged 76 and older; urinalysis or urine culture for non-specific reasons in women aged 65 and older; and one intermediate outcome measure: hemoglobin A1c less than 7.0 in adults aged 75 and older with diabetes mellitus treated with insulin or oral hypoglycemic medication. RESULTS: Sixty-nine clinicians and 2009 patients contributed observations to the PSA measure, 144 clinicians and 5933 patients contributed to the urinalysis/urine culture measure, and 42 clinicians and 665 patients contributed to the diabetes measure. Meaningful clinician-level performance variation was greatest for the PSA measure (intraclass correlation coefficient [ICC] = 0.27), followed by the urinalysis/urine culture measure (ICC = 0.18), and the diabetes measure (ICC = 0.024). The range of possible overuse across clinician quartiles was 8-54% for the PSA measure, 3-35% for the urinalysis/urine culture measure, and 13-49% for the diabetes measure. The odds ratios of overuse in the highest quartile compared with the lowest for the PSA, urinalysis/urine culture, and diabetes measures were 99.3 (95% CI 43 to 228), 15.7 (10 to 24), and 6.0 (3.3 to 11), respectively. CONCLUSIONS: Within the same health system, rates of potential overuse in elderly patients varied greatly across clinicians, particularly for the process measures examined.
IMPORTANCE: The extent of clinician-level variation in the overuse of testing or treatment in older adults is not well understood. OBJECTIVE: To examine clinician-level variation for three new measures of potentially inappropriate use of medical services in older adults. DESIGN: Retrospective analysis of overall means and clinician-level variation in performance on three new measures. SUBJECTS: Adults aged 65 years and older who had office visits with outpatient primary or immediate care clinicians within a single academic medical center health system between July 1, 2016, and June 30, 2017. MEASURES: Two electronic clinical quality measures representing potentially inappropriate use of medical services in older adults: prostate-specific antigen testing against guidelines (PSA) in men aged 76 and older; urinalysis or urine culture for non-specific reasons in women aged 65 and older; and one intermediate outcome measure: hemoglobin A1c less than 7.0 in adults aged 75 and older with diabetes mellitus treated with insulin or oral hypoglycemic medication. RESULTS: Sixty-nine clinicians and 2009 patients contributed observations to the PSA measure, 144 clinicians and 5933 patients contributed to the urinalysis/urine culture measure, and 42 clinicians and 665 patients contributed to the diabetes measure. Meaningful clinician-level performance variation was greatest for the PSA measure (intraclass correlation coefficient [ICC] = 0.27), followed by the urinalysis/urine culture measure (ICC = 0.18), and the diabetes measure (ICC = 0.024). The range of possible overuse across clinician quartiles was 8-54% for the PSA measure, 3-35% for the urinalysis/urine culture measure, and 13-49% for the diabetes measure. The odds ratios of overuse in the highest quartile compared with the lowest for the PSA, urinalysis/urine culture, and diabetes measures were 99.3 (95% CI 43 to 228), 15.7 (10 to 24), and 6.0 (3.3 to 11), respectively. CONCLUSIONS: Within the same health system, rates of potential overuse in elderly patients varied greatly across clinicians, particularly for the process measures examined.
Authors: Lindsay E Nicolle; Suzanne Bradley; Richard Colgan; James C Rice; Anthony Schaeffer; Thomas M Hooton Journal: Clin Infect Dis Date: 2005-02-04 Impact factor: 9.079
Authors: Ciara Pendrith; Meghan Bhatia; Noah M Ivers; Graham Mecredy; Karen Tu; Gillian A Hawker; Susan B Jaglal; Lynn Wilson; Kimberly Wintemute; Richard H Glazier; Wendy Levinson; R Sacha Bhatia Journal: CMAJ Open Date: 2017-01-20
Authors: Kasia J Lipska; Joseph S Ross; Yinghui Miao; Nilay D Shah; Sei J Lee; Michael A Steinman Journal: JAMA Intern Med Date: 2015-03 Impact factor: 21.873
Authors: Sheldon Greenfield; Sherrie H Kaplan; Richard Kahn; John Ninomiya; John L Griffith Journal: Ann Intern Med Date: 2002-01-15 Impact factor: 25.391
Authors: Derek LeRoith; Geert Jan Biessels; Susan S Braithwaite; Felipe F Casanueva; Boris Draznin; Jeffrey B Halter; Irl B Hirsch; Marie E McDonnell; Mark E Molitch; M Hassan Murad; Alan J Sinclair Journal: J Clin Endocrinol Metab Date: 2019-05-01 Impact factor: 5.958
Authors: Daniel J Morgan; Sanket S Dhruva; Eric R Coon; Scott M Wright; Deborah Korenstein Journal: JAMA Intern Med Date: 2018-01-01 Impact factor: 21.873
Authors: Tiffany Brown; Theresa A Rowe; Ji Young Lee; Lucia C Petito; Ryan Chmiel; Jody D Ciolino; Jason N Doctor; Craig R Fox; Noah J Goldstein; Darren Kaiser; Jeffrey A Linder; Daniella Meeker; Yaw Peprah; Stephen D Persell Journal: Contemp Clin Trials Date: 2021-12-08 Impact factor: 2.226
Authors: Theresa A Rowe; Tiffany Brown; Jason N Doctor; Jeffrey A Linder; Stephen D Persell Journal: BMC Fam Pract Date: 2021-05-15 Impact factor: 2.497
Authors: David C Mohr; Libin Zhang; Julia C Prentice; Richard E Nelson; Donglin Li; Erin Pleasants; Paul R Conlin Journal: BMJ Open Diabetes Res Care Date: 2022-07